托拉塞米注射液治疗急性左心衰竭的临床疗效分(2)

2014-03-22 02:33

导读：[1] FortunoA, MunizP, RavassaS, etal. Torsaemidinhibitsangiotensi Ⅱ induced vasoconstriction and intracellular calciumincrease in the aorta of spontaneously hypertensive rate[J]. Hypertension, 1999,

　[1] FortunoA, MunizP, RavassaS, etal. Torsaemidinhibitsangiotensi Ⅱ induced vasoconstriction and intracellular calciumincrease in the aorta of spontaneously hypertensive rate[J]. Hypertension, 1999, 34(1): 138143.

　　[2] Shilliday IR, Allison ME. Intraplatelet Calcium Level in with acute renal failure beforece and after the administration of loop diurefics.[J]. Nephrol Dial Transplant, 2001, 16(3): 552555.

　　[3] Lopez B, Gonzalez A, Beaumont J, et al. Identification of a potential cardiac antifibrotic mechanism of torasemide in patients with chronic heart failure[J]. Journal of the American College of Cardiology, 2007, 50(9): 859867.

　　[4] Preobrazhenskii DV, Sidorenko BA, Tarykina EV, et al.[Torasemide-new generation loop diuretic: clinical pharmacology and therapeutic application][J]. Kardiologiia, 2006, 46(10): 7586.

　　[5] Muller K, Gamba G, Jaquet F, et al. Torasemide vs. furosemide in primary care patients with chronic heart failure NYHA Ⅱ to Ⅳ efficacy and quality of life[J].Eur J Heart Fail, 2003, 5(6): 793801

上一篇：美托洛尔治疗慢性心力衰竭36例疗效观察下一篇：没有了